Structure-based design of novel THR-β agonists and mechanism of activation research by molecular dynamics simulations
Bioorganic & Medicinal Chemistry · 2025
DOI: 10.1016/j.bmc.2025.118397 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic & Medicinal Chemistry, 2025. Verfasst von Yang Gao und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy and Minhang Hospital, Fudan University, Shanghai 201203, China. Hauptthemen laut MEDLINE: Molecular Dynamics Simulation, Drug Design, Thyroid Hormone Receptors beta. Die Arbeit nennt 34 Literaturangaben. Gefördert von: Science and Technology Commission of Shanghai Municipality, National Natural Science Foundation of China.
Abstract (Originalsprache)
Thyroid hormone receptor β (THR-β) plays a crucial role in regulating lipid metabolism, steatohepatitis, and liver fibrosis. The approval of Resmetirom has demonstrated the therapeutic potential of THR-β agonism in treating metabolic-associated steatohepatitis (MASH). Therefore, investigating the mechanism of THR-β activation is essential for understanding its mode of action and further research. In this study, we report a newly designed THR-β agonist, D4, which exhibits superior in vitro activity, with a Ki value of 257.3 nM, providing a valuable tool for exploring receptor activation. To gain mechanistic insights, we conducted 500 ns molecular dynamics (MD) simulations on three systems: THR-β bound to agonist D4, THR-β bound to a known antagonist 6, and apo THR-β (ligand-free). A detailed analysis of the structural stability and activation mechanism of these systems was performed. Our findings suggest a novel activation mechanism in which a dynamic salt bridge relay, mediated by Loop-H11-H12, stabilizes the active state of the receptor. In addition, key hydrophobic interaction formed by antagonist and carbon chain of Arg438 was found to be crucial for ligands to switch from agonist to antagonist.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy and Minhang Hospital, Fudan University, Shanghai 201203, China.
- Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
- Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210023, China.
- Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China. Electronic address: jli@simm.ac.cn.
- School of Pharmacy and Minhang Hospital, Fudan University, Shanghai 201203, China. Electronic address: wfu@fudan.edu.cn.
Förderung
- Science and Technology Commission of Shanghai Municipality
- National Natural Science Foundation of China
Zitieren
APA
Gao, Y., Zhu, H., Gao, L. X., Xu, G. Y., Lin, J., Sun, L., Li, W., Li, J., & Fu, W. (2025). Structure-based design of novel THR-β agonists and mechanism of activation research by molecular dynamics simulations. Bioorganic & Medicinal Chemistry. https://doi.org/10.1016/j.bmc.2025.118397
Vancouver
Gao Y, Zhu H, Gao LX, Xu GY, Lin J, Sun L, et al. Structure-based design of novel THR-β agonists and mechanism of activation research by molecular dynamics simulations. Bioorganic & Medicinal Chemistry. 2025. doi:10.1016/j.bmc.2025.118397
BibTeX
@article{Gao2025,
author = {Gao, Yang and Zhu, Haoran and Gao, Li-Xin and Xu, Gao-Ya and Lin, Jing and Sun, Lujie and Li, Wei and Li, Jia and Fu, Wei},
title = {Structure-based design of novel THR-β agonists and mechanism of activation research by molecular dynamics simulations},
journal = {Bioorganic & Medicinal Chemistry},
year = {2025},
doi = {10.1016/j.bmc.2025.118397}
}
EUVIMED